Senator Mike Braun @SenatorBraun
Promising Pathway Act requires FDA to use a rolling, priority review pathway to evaluate drugs intended to treat, prevent, or diagnose serious diseases. Provisional approval is granted to drugs demonstrating substantial evidence of safety & early evidence of positive outcomes. — PolitiTweet.org